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Chronic metabolic acidosis accelerates whole body proteolysis
and oxidation in awake rats
ROBERT C. MAY, TAHSIN MASUD, BRIAN LOGUE, JAMES BAILEY, and BRIAN ENGLAND
Renal Division, Emo,y University School of Medicine, Atlanta, Georgia, USA
Chronic metabolic acidosis accelerates whole body proteolysis and
oxidation in awake rats. Previous work has documented an acceleration
of proteolysis and branched-chain amino acid oxidation when muscles
from rats with chronic metabolic acidosis were incubated in vitro. The
present study examines the impact of chronic metabolic acidosis on
whole body amino acid turnover and oxidation in chronically catheter-
ized awake male Sprague-Dawley rats using stochastic modeling and a
primed continuous infusion of L-[l-'4C] leucine. Whole body protein
turnover was accelerated by acidosis as reflected in a 70% increase in
proteolysis and a 55% increase in protein synthesis. Amino acid
oxidation was increased 145% in rats with chronic metabolic acidosis
relative to control rats receiving diets identical in protein and calories
based on a reciprocal pool model and plasma a-ketoisocaproate specific
radioactivity. These changes were accompanied by a 104% increase in
liver branched-chain ketoacid dehydrogenase (BCKAD) activity in rats
with acidosis, similar to previously documented increases in skeletal
muscle BCKAD activity caused by acidosis. In contrast, kidney
BCKAD activity was decreased 38% by acidosis, illustrating the
tissue-specificity of the changes that were present. We conclude that
chronic metabolic acidosis accelerates whole body protein turnover and
affects the reincorporation of amino acid into body proteins by accel-
erating amino acid oxidation.
Chronic metabolic acidosis has been implicated as the cause
of several abnormalities in muscle protein metabolism. There
was an acceleration of intracellular muscle proteolysis when
epitrochlearis muscles from rats with chronic metabolic acido-
sis were incubated [1]. These findings could not be reproduced
by either placing muscles from normal rats in acidified media,
nor by perfusing the hindquarter of normal rats with acidified
media. Moreover, the apparent catabolic effect of acidosis on
incubated muscle was not reversed by incubating muscles from
acidotic rats in normal pH media. We concluded that either
chronic exposure to acidosis, or perhaps some additional in
vivo signal accompanying metabolic acidosis in vivo might be
related to this catabolic effect on incubated muscles [1]. Fuller
and colleagues have examined the effects of extracellular alka-
losis on cardiac muscle protein turnover and have determined
that alkalosis is associated with a stimulation of protein synthe-
sis, and a reduction of protein degradation [2]. Whether acidosis
would have a catabolic response on cardiac muscle remains to
be determined. Lastly, England, Chastain and Mitch have
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found that extracellular acidosis increases intracellular proteo-
lysis in the muscle cell line, BC3H1 [31. The extent to which
these in vitro muscle findings accompanying acidosis are
present in vivo and the effects of such changes on overall
protein turnover remain unknown.
In addition to the effects of acidosis on proteolysis in incu-
bated tissues, acidosis is associated with abnormalities of
branched-chain amino acid (BCAA) metabolism. We have
found an acceleration in the oxidative decarboxylation of valine
and leucine when epitrochlearis muscles from acidotic rats were
studied in vitro [4]. Similar to muscle proteolysis, the acceler-
ation in BCAA catabolism could not be reproduced by incubat-
ing muscles from normal rats in acidified media. The accelera-
tion in BCAA catabolism was not due to any changes in net
amino acid transamination, but rather appeared to be due to
changes in the activity of branched-chain keto acid dehydroge-
nase (BCKAD), the rate-limiting enzyme of BCAA catabolism
in skeletal muscle [4, 5]. The impact of metabolic acidosis in
BCKAD activity from tissues other than skeletal muscle has not
been determined.
The applicability of in vitro muscle studies to in vivo metab-
olism remains controversial. For instance, Preedy and Garlick
have shown that many of the assumptions concerning protein
turnover in the perfused rat hindquarter method as a model for
muscle protein turnover may be invalid [6]. Others have cau-
tioned about extrapolating findings concerning protein turnover
obtained from incubated muscle experiments to the in vivo
situation given the complexities of amino acid metabolism in the
intact animal and the limitations of the in vitro models [7—9].
Therefore, the applicability of any apparent catabolic effect of
acidosis on incubated muscles to in vivo protein metabolism
remains unanswered.
However, certain findings do suggest that chronic metabolic
acidosis is associated with catabolic changes in vivo. Acidosis
is associated with stunted growth, and increased nitrogen
excretion despite dietary protein intakes no different from the
control animals [1]. Whether this apparent catabolic effect is
accompanied by changes in the determinants of protein turn-
over, namely protein synthesis and degradation, is unknown.
Moreover, plasma BCAA concentrations are lowered by met-
abolic acidosis despite identical dietary protein intake, suggest-
ing that acidosis stimulates the breakdown of BCAA. At least a
portion of the accelerated BCAA breakdown may result from
acidosis-induced changes in skeletal muscle, since there is an
apparent stimulation of BCKAD activity when determined from
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skeletal muscles freeze-clamped in situ from rats with chronic
metabolic acidosis [4]. Since a variety of other tissues play
significant roles in BCAA metabolism in addition to skeletal
muscle, it remains unclear to what extent any changes in BCAA
handling may affect plasma BCAA levels.
A variety of techniques have been employed to examine the
turnover rate of amino acids in the whole animal [10—14]. The
most widely employed method involves stochastic modeling of
amino acid turnover under steady-state infusion of amino acids.
We used this technique in chronically-catheterized awake unan-
esthetized rats to examine how chronic metabolic acidosis
affects whole body protein turnover. The present report dem-
onstrates that chronic metabolic acidosis increases whole body
protein turnover, and accelerates amino acid oxidation. These
findings are associated with a stimulation in liver BCKAD
activity while suppressing kidney BCKAD activity and hence
underscore the importance of muscle and liver BCKAD activity
in the regulation of BCAA metabolism in pathophysiologic
states.
Methods
Animals
Male Sprague-Dawley rats weighing 150 to 175 g (Harlan
Sprague-Dawley Inc., Indianapolis, Indiana, USA) were
housed in temperature-controlled quarters with a 12 hour light-
dark cycle, and given water and 22% protein pellets (Purina
Animal Chow, Inc.) ad libitum. Over three to four days,
gavage-feeding with a diet containing 14% casein gradually
replaced the pellets. Twelve grams per day of the diet were
mixed (5:3, wt/vol) with water (control), or a solution of NH4CI
so as to provide 4 mmol/l00 g body weight/day (acid), and fed
in 8 ml aliquots twice daily for five days as described previously
[11. The acid group was given 0.25 M NH4C1 to drink ad libitum;
control rats drank water. Three to seven days prior to the
experiment, rats were anesthetized with sodium pentobarbitol
(50 mg/kg i.p.), a PE 50 polyethylene catheter placed in the
jugular vein, and a silastic catheter (Dow Corning, ID = 0.02
in.) was inserted into the femoral vein and threaded 5 cm into
the inferior vena cava. The femoral catheter was secured by
ligature over a 23 gauge metal stent. Both catheters were kept
patent by a solution of polyvinylpyrrolidone (160 gldl) in
heparinized saline (20 U/ml) [151, and tunneled subcutaneously
to exit between the scapulae. The exit site was embedded in a
fold of dorsal skin created by skin ligatures which were released
at the time of the experiment. Following placement of the
catheters rats were kept in individual wire-bottom cages to
prevent coprophagia and examined daily for signs of infection.
The evening before the experiment rats received only NH4CI or
water but no food to ensure that the experiments were con-
ducted under postabsorptive conditions.
Amino acid infusions
On the day of the experiment the catheters were flushed with
heparinized saline; the jugular catheter was used for the leucine
infusions and the inferior vena cava catheter was used for blood
drawing. Rats received loading doses of 4 pCi NaH'4CO5 and 4
pCi L-[l-'4C] leucine followed by a continuous infusion of 20
pCi L-[1-'4C] leucine in sterile saline (final volume = 10 ml) at
0.035 ml/min for 240 minutes. A loading dose of NaH14CO3 was
required in order that the specific radioactivity of plasma
H'4C03 reached an equilibrium value by 150 minutes into the
infusion, and hence expired '4C02 would reflect the rate of
L-[l-14C] leucine oxidation [121. During the infusion rats were
housed in a sealed cage through which 1.1 liter room air was
circulated each minute. Eighty minutes after the start of the
infusion and again at 100, 120, 150, 180, 210, and 240 minutes,
the air exiting from the cage was bubbled through a C02-
trapping solution of hyamine (6 pM final concentration in 200 ml
ethanol) and phenophthalein until the solution became color-
less. '4C02 was determined by liquid scintillation counting
(LSC); trapped CO, was calculated by titrating an equal volume
of the solution with a known amount of CO2 and subtracting the
contribution made by CO2 in room air. To determine the
efficiency of 14C0, trapping, acid was infused into the flask
containing a known amount of NaH'4C03 inside the sealed
cage, and the liberated '4C02 trapped in the hyamine solution
was quantitated by LSC and expressed as per cent total
NaH'4C03 initially present in the flask. Using this protocol and
200 ml of trapping solution, 99% of the original NaH14CO3 was
trapped. Beginning at 150 minutes, and every 30 minutes
thereafter up to 240 minutes, a 200 td sample of blood was
obtained from the IVC catheter. At the end of the experiment,
the rats received pentobarbitol (100 mg/kg, i.v.) followed by a
laparotomy. Kidney and liver were rapidly frozen in situ using
aluminum tongs precooled in liquid nitrogen; a sample of aortic
blood was obtained anaerobically. A portion of aortic blood was
used for blood gas analysis; the remainder was used for
ketoacid analysis. The tissue biopsies were frozen at —70°C
until analyzed for BCKAD activity. Rats were sacrificed with-
out recovering from anesthesia.
In separate experiments, acidotic or control rats received a
continuous infusion of NaH'4C03 (20 pCi in 0.9% NaCI, final
volume 10 ml) at 0.035 mI/mm. The rate of '4C0, excretion
was measured every 30 minutes for 240 minutes. The steady
state rate of 14C02 excretion was compared with the rate of
NaH'4C03 infusion, and this ratio was used to correct for
differences in CO2 recovery [121. There was no apparent
difference in the recovery rate for 14C02 when comparing
results from acidotic rats with control rats (90 5%, acid, N
4 vs. 92 2%, control, N = 4). Hence, '4C02 was divided by
0.90 for the acidotic rats and 0.92 for the control rats in order to
correct the results for the percent recovery.
Analyses
Branched-chain ketoacid dehydrogenase activity was mea-
sured on crude liver and kidney homogenates using the method
of Harris and colleagues [16]. This method does not change the
phosphorylation state of the BCKAD complex, and should
reflect the activity of the enzyme in vivo. Frozen liver or kidney
samples were pulverized under liquid nitrogen and allowed to
thaw in buffer containing 50 m potassium HEPES (pH 7.5),
200 msi KCI, 3 m EDTA, 5 m DTT, 100 LM N-tosyl-L-lysine
chioromethyl ketone, 0.5 JLM leupeptin, 1 g/ml aprotinin, 2%
rat serum, 0.5% Triton X-100, and 100 /SM a-chloroisocaproate
(10 g%, tissue to buffer). Tissues were homogenized at 4°C
using a polytron (Brinkman Instruments Inc., Westbury, New
York, USA) at a setting of 3 for 30 seconds. The assay buffer
contained the following: 50 mM potassium phosphate (pH =
7.5), 3 m NAD, 0,4 sM thiamine pyrophosphate, 0.4 M
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coenzyme A, 2 mi DTT, 10 msi MgSO4, 0.1% Triton X-l00.
The substrate used to determine liver and kidney BCKAD
activity was [1-'4C] a-ketoisovaleric acid (a-KIV) formed from
L-[l-'4C] valine by the Rudiger reaction [17] followed by
separation on a Dowex cation-exchange column, since use of
a-ketoisocaproic acid (a-KIC) overestimates liver BCKAD
activity [18].
A 200 p1 aliquot of the tissue homogenate was added to 200 p1
of the assay buffer and allowed to reach thermal equilibrium in
a 1.5 ml microfuge tube suspended inside a miniscintillation vial
containing 750 p1 hyamine (1 M in methanol) at 30°C. The
reaction was begun by adding 50 p1 of 4 mM a-ketoisovaleric
acid containing [l-'4C] a-ketoisovaleric acid (50,000—100,000
DPM/assay), and incubating the sealed tubes at 30°C for eight
minutes. Preliminary experiments indicated that the amount of
evolved '4C02 was linear for up to 12 minutes of incubation
under identical conditions. All samples were done in quadru-
plicate. The reaction was stopped by adding 400 p1 of 20%
perchloric acid (PCA) to the microfuge tubes, followed by an
additional incubation of the sealed tubes at 40°C for three hours
in order to evolve '4C02 [16]. Trapped '4C02 in hyamine was
mixed in a 5 ml scintillation cocktail and determined by LSC.
All assays were corrected for volatility of the initial label by
incubating 400 p1 of homogenization buffer with 400 1d of assay
buffer containing [l-'4C] a-ketoisovaleric acid under identical
conditions.
The protein pellet was washed in 800 p1 of 10% PCA,
followed by two separate washes with 800 p1 ethanol/ether
(50/50, vol/vol). The washed pellet was solubilized overnight at
37°C in 1 ml 1 N NaOH, and protein content was measured by
the Lowry method [19] using bovine albumin as the external
standard. BCKAD activity was expressed in tmoles of decar-
boxylated KIV per minute per mg tissue protein. The coefficient
of variation for BCKAD activity for the tissue samples from
control rats was 11 2%, and for the samples from acidotic rats
was 13 1%.
Plasma samples were deproteinized with sulphosalicylic acid
(final concentration = 6%, wt/vol), and applied to a Dowex
X-18 (H, 200 mesh) cation exchange column (bed volume = 400
p!). The initial eluate was again passed through the Dowex
column, followed by washing the column with 2 bed volumes of
0.01 N HC1; the initial Dowex-treated eluate was combined with
the washings and used for ketoacid analysis. The Dowex
column was then washed with 5 bed-volumes of HPLC-grade
H20 and amino acids eluted with 8 bed-volumes of 4 N NH4
OH/ethanol (95/5, vol/vol) [20]. The amino acid eluate was dried
overnight on a Speed-Vac, and then reconstituted in twice the
original volume using HPLC-grade H20 to which the internal
standard, fluorophenylalanine (final concentration = 50 tM)
was added.
Amino acids underwent precolumn derivatization for 1.8
minutes with o-pthalaldehyde (OPA) using an automatic injec-
tor (Waters Model 7 lOB) and a mixing chamber. The OPA was
prepared fresh daily by dissolving 50 mg OPA in I ml HPLC-
grade methanol, and the solution added to 1 M potassium
borate, pH = 10.4 (Fluoraldehyde Reagent Diluent, Pierce
Chemicals, Rockford, Illinois, USA, final volume = 10 ml) and
40 p1 HPLC-grade /3-mercaptoethanol. Derivatized amino acids
were separated by reversed-phase HPLC on a 25 cm x 4.6 mm
C18 column using a gradient program as described previously
[4]. The internal standard and branched-chain amino acids were
identified by their characteristic retention times, and quanti-
tated by fluorescence detection (excitation 340 nm, emision 455
nm) in comparison to external standards of known concentra-
tion [4, 21]. In preliminary experiments, samples were spiked
with a known amount of [1-'4C] a-ketoisocaproate or
NaH'4CO3 prior to the Dowex separation step. We found that
<1% of the final radioactivity in the reconstituted amino acid
fraction could be accounted for by contaminating ketoacid or
bicarbonate. Therefore, L-[ I-' 4C] leucine specific radioactivity
was determined by measuring the radioactivity present in an
aliquot of the reconstituted amino acid solution, and separately
determining the concentration present in the same solution.
Ketoacids were assayed by a modification of the method of
Ali Qureshi [221. The acidified deproteinized samples which had
been separated using the cation-exchange column were mixed
with a known amount of c-ketocaproic acid as an internal
standard and then extracted three times into 5 ml of iced,
water-saturated ether for five minutes. In turn, each ether
extraction was back-extracted into the same 1 ml of 20 ms'i
phosphate (pH = 6.7) [231. After the final phosphate extraction,
the pH of the buffer was checked to ensure that the buffering
capacity had not been exceeded since acidification of the
phosphate buffer would greatly affect the efficiency of back-
extraction. The ether extraction step was used because we
found minor unidentified peaks which could not be readily
resolved from the internal standard when this step was not
included. Ketoacids were derivatized with o-phenylenediamine
(OPD) using freshly recrystallized OPD prepared daily (50 mg
OPD in 20 ml of 1 N HC1 and 200 p1 f3-mercaptoethanol). One
milliliter of phosphate buffer was added to 250 jsl 0.1 M acetic
acid, 500 p1 1 M NaCl, 1 ml OPD, and the solution capped and
heated at 80°C for 120 minutes. Following the derivatization the
tubes were cooled on ice for 10 minutes and vigorously vor-
texed after the addition of 1 ml saturated Na2SO4C. The reacted
products were extracted into 4 ml of water-saturated, HPLC-
grade CHCI3 over five minutes, and centrifuged at 5000 RPM X
5 minutes to facilitate separation into phases. Three of the 4 ml
of chloroform were treated with 500 mg of anhydrous Na2SO4,
and the chloroform extract dried under N2, and reconstituted in
50% of the original volume using dimethylformamide/mobile
phase A (1/1, vol/vol).
Ketoacids were separated using reversed-phase HPLC on a
25 cm x 4.6 mm C8 column. Mobile phase A = 95% sodium
acetate (50 mivi, pH = 5.9), 5% acetonitrile, and mobile phase B
= 10% sodium acetate, 40% methanol, 50% acetonitrile. The
initial elution used 90% A followed by a convex curvilinear
gradient to 60% A by 10 minutes, followed by a linear gradient
to 45% A by 30 minutes, and then a step-wise increase to 100%
B over the next minute which was sustained over the subse-
quent seven minutes. Ketoacids were detected by spectrofluo-
rometry (excitation 340 nm, emission 450 nm) using a Shimadzu
RF 551 fluorescence detector. a-ketoisocaproate was quanti-
tated in comparison to external standards of known concentra-
tion. The internal standard, a-ketocaproate, was used to correct
for any differences in percent yield or in injection volume. The
interassay coefficient of variation was 4.6%. Less than 2% of
the a-KIC was bound to the Dowex column. Plasma -ketoiso-
caproate specific radioactivity was performed on the final
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Table 1. Plasma electrolyte and mean plasma branched-chain amino acid concentrations in acidotic and control rats
Type
PUN
mg%
Na K HCO3 Valine Leucine Isoleucine
mEqiliter M
Acid 23 1 138 2 3.1 0.2 12 l 113 ma 104 7 49
Control 18±2 141±1 3.8±0.1 21± 2 147 132±4 69±4
Plasma electrolyte, urea, and branched-chain amino acid concentrations from acidotic and control rats. Electrolyte and urea values are reported
for cohorts of 7 acidotic and 4 controls. Branched-chain amino acid levels were measured for 11 acidotic and 14 control rats. Results are expressed
as means SEM.
a p < 0.05 vs. controls
plasma sample obtained. In two separate preliminary experi-
ments it was determined at 150 minutes and again at 240
minutes and the two values were found to be in good agreement
(117444, 150 mm vs. 125636, 240 mm, and 105703, 150 mm vs.
111567 DPM/mol a-KIC, 240 mm).
To calculate the percent yield of a-ketoisocaproate, external
standards were spiked with a known amount of [1-14C] a-ke-
toisocaproate after the Dowex separation step and the radioac-
tivity present in the reconstituted samples following derivatiza-
tion was compared with the amount of radioactivity initially
present. Recovery was 70 1% (N = 5); there was no apparent
difference in the recovery of a-ketoisocaproate compared with
a-ketocaproate. Using L-[1-'4C} leucine and NaH'4C03 in
additional preliminary experiments, we found that <1% of the
initial radioactivity was present in the reconstituted ketoacid
fraction. Therefore, the a-KIC specific radioactivity was deter-
mined by separately determining the radioactivity present and
measuring the a-KIC concentration present in the reconstituted
ketoacid fraction. The percent recovery was used to correct the
final plasma a-ketoisocaproate specific radioactivity.
Calculations
Standard formulae were used to calculate rates of amino acid
flux, oxidation, and protein synthesis [121. Briefly, under stead-
state conditions, the following formulae were used:
flux = total proteolysis = infusion rate of
'4C-Leu/specific radioactivity
Oxidation = net proteolysis =
production/specific radioactivity
where '4C02 production is divided by the fractional
recovery of '4C02.
protein synthesis = flux — oxidation
For each rat, the leucine specific radioactivities and '4C02
production from each of the time points from 150 minutes to 240
minutes were summed, and means of these values were used to
provide a single value for flux, oxidation, and protein synthesis.
Statistics
Results are expressed as means SEM. A two-tailed unpaired
Student's 1-test was used to compare results from acidotic rats
versus control rats. Differences are considered significant at P
< 0.05. When expressing the variability of plasma leucine
specific radioactivity and expired '4C02 specific radioactivity
between 150 and 240 minutes, the specific radioactivities from
each separate time point were expressed as a percent of the
mean specific radioactivity between 150 and 240 minutes; for
each experimental group these percents are summed and are
represented graphically as means SEM. The coefficient of
variation (CV) in expired '4C02 and plasma leucine specific
radioactivity was calculated for each animal as the standard
deviation of these values divided by the mean specific radioac-
tivity from the time interval between 150 and 240 minutes. The
CV for animals from each group are combined to give an
additional quantitation of the variability of these measures for
each group during this time interval.
Materials
All HPLC analyses were performed using columns purchased
from Supelco (Philadelphia, Pennsylvania, USA) on a Waters
(Medford, Massachusetts, USA) system including two model
640 pumps, an automatic WISP injector, and either a model 410
spectrofluorometer (amino acids) or Shimadzu RF 551 spectro-
fluorometer (ketoacids). OPD, which was electrophoretically-
pure grade, and OPA were both from Pierce Chemical (Chica-
go, Illinois, USA). The L-amino acid oxidase and catalase were
from Boennger Mannheim. L-[l-14C] leucine and L-[1-14C]
valine were purchased from ICN Biomedical, Inc. (Costa Mesa,
California, USA), and [1-14C] s-ketoisocaproate was from
Amersham Corp. (Arlington Heights, Illinois, USA). All LSC
determinations were performed on a Beckman Model LS 1800
using Hionic-Fluor scintillation cocktail (Packard Instruments,
Downers Grove, illinois, USA). General chemicals were pur-
chased from Sigma Inc. (St. Louis, Missouri, USA), and
HPLC-grade solvents were obtained from Fisher (Pittsburgh,
Pennsylvania, USA). Venous blood bicarbonates were either
measured directly using an Astra 8 Analyzer (Beckman), or
calculated from pH and pCO2 (Corning blood gas analyzer).
Plasma sodium, potassium, and urea nitrogen were measured
using an Astra 8 Analyzer. Animals were studied using the
small animal metabolic unit model 360 from Ametek (Pitts-
burgh, Pennsylvania, USA). Sandoz Pharmaceuticals Corp.
provided the a-chloroisocaproate.
Results
The blood bicarbonate in a cohort of acidotic animals was 12
1 mM, versus 21 2 m, controls (Table 1); these values are
similar to those obtained in our prior studies [1, 41. In addition
to the changes in the blood bicarbonate values, there was a
slight decrease in plasma potassium and an increase in the
plasma urea nitrogen concentration in the acidotic rats when
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Type
Branched-chain ketoacid dehydrogenase
activity /2mol/min/mg protein
Liver Kidney
Acidotic 10.12 1.43a 6.79 0.77a
Control 4.95 0.66 11.01 1.24
compared to the controls (Table 1). Plasma branched-chain
amino acid concentrations were measured several times in each
fasted rat during the time course of the leucine infusions. The
mean of these concentrations was determined for each rat and
the mean concentrations were averaged for each group. Plasma
leucine, valine, and isoleucine were significantly depressed in
rats with chronic acidosis compared with control rats receiving
an identical intake of all three of the branched-chain amino
acids (Table 1).
Branched-chain ketoacid dehydrogenase activity in liver and
kidney of rats with acidosis was compared with values from
control rats. Similar to muscle BCKAD differences determined
previously [41, there was a 104% increase in BCKAD activity in
livers obtained from rats with metabolic acidosis compared with
the controls (Table 2). These differences are especially striking
in view of the lower plasma leucine concentrations of acidotic
rats and the identical dietary protein intake in each group, since
differences in protein intake and especially plasma leucine
concentrations are known to affect the activity state of muscle
and liver BCKAD by affecting the phosphorylation of the a
subunit of the E1 subunit of the enzyme [101. In contrast,
BCKAD activity was decreased 38% (P < 0.025) in kidneys
obtained from acidotic rats compared with their controls. Thus,
the effects of chronic metabolic acidosis on BCKAD activity
are tissue-specific since liver BCKAD activity was stimulated
while kidney BCKAD activity was depressed in the same
acidotic rats compared to control samples.
To characterize the stability of the preparation during the
time interval from 150 to 240 minutes, plasma leucine and
expired 14C02 specific radioactivities were expressed as a
percent of the mean for values obtained during that time
interval. As is apparent from Figure 1, '4C02 specific radioac-
tivity in expired gas was constant from 150 to 240 minutes for
both acidotic as well as control rats. From 150 to 240 minutes
the C.V. for expired '4C02 specific radioactivity of the acid
group was 10.3 2.0% and the C.V. of the control rats was 10.0
1.6%. There was greater variation in the plasma leucine
specific radioactivity during this time interval (C.V. acid rats
12.1 2.1% vs. C.V. control rats 15.7 2.0%). However, there
was no apparent systematic variation in leucine specific radio-
activity during this time interval nor was there any striking
difference between acidotic and control rats (Fig. 2). These data
are consistent with there being a constant specific radioactivity
of a-ketoisocaproate between 150 and 240 minutes.
When plasma a-ketoisocaproate specific radioactivities were
compared with the mean of plasma leucine specific radioactiv-
ities, there was a significantly lower ratio in the acidotic rats
I.
150 180 210 240 150 180 210 240
Time, minutes into infusion
Fig. 1. CO2 spec jfic radioactivity of expired air from acidotic or
control rats is expressed for each of the time points as a percent of the
mean CO2 specific radioactivity from 150 to 240 minutes after the
beginning of the infusion. The bars represent the SEM for each time
point.
40
150 180 210 240 150 180 210 240
Time, minutes into in fusion
Fig. 2. Plasma leucine specific radioactivity from acidotic or control
rats is expressed for each of the time points as a percent of the mean
leucine specific radioactivity from 150 to 240 minutes after the be gin-
ning of the infusion. The bars represent the SEM for each time point.
relative to the control group (69 6%, acid vs. 84 4% control,
P < 0.05). This suggests that intracellular leucine specific
radioactivity was lower in the rats with metabolic acidosis [121.
There was a 50% increase in the amino acid flux rate
(proteolysis) in the acidotic animals compared with control rats
when fluxes were based on plasma leucine specific radioactiv-
ities (Table 3). Since amino acid flux is calculated as the ratio of
infused tracer for amino acid specific radioactivity corrected for
weight, and since the infusion rate for the tracer did not differ
between the two groups, it follows that the differences in amino
acid flux was reflected in the higher leucine specific radioactiv-
ities present in the control group. This is especially noteworthy
in view of the lower plasma leucine concentrations (Table 1)
present in the acidotic rats. Similarly, amino acid oxidation
Table 2. Branched-chain ketoacid dehydrogenase activity of liver
and kidney homogenates obtained from acidotic and control rats A Acidosis B Control
Branched-chain ketoacid dehydrogenase activity on liver and kidney
homogenates from acidotic and control animals. Values represent mean
5EM from 6 rats in each group.
a P < 0.05 vs. control
III'
a)
E
120
80
40
A Acidosis B Control
120
80
C
a)
E
1540 May et al: Acidosis accelerates whole body proteolysis
Table 3. Am
plasma
mo acid turnover based on reciprocal pool model using
leucine or a-ketoisocaproate specific radioactivity
Protein
Group
Flux Oxidation synthesis
p,mol leucinellOO g wt/hr
Acidosis 47.1 7.8a 12.8 0.6a 34.3 6.0
Control 30.1 2.0 6.1 0.6 24.3 1.8
Protein
Group
Flux Oxidation synthesis
jimol a-ketoisocaproate/100 g wt/hr
Acidosis 64.0 5.& 15.7 I.3 48.4 s.oa
Control 37.6 2.7 6.4 0.4 31.2 2.8
Results are presented as means 5EM for acidotic (N = 11) and
control rats (N = 14),
a P C 0.05 vs. control
rates, which is the algebraic equivalent of net protein degrada-
tion under fasting conditions, was more than doubled in the
acidotic rats relative to their controls (Table 3). Although
protein synthesis rates appeared to be higher in acidotic rats,
these differences did not achieve statistical significance when
rates were calculated on the basis of leucine specific radioactiv-
ities.
The increases in both protein degradation and BCAA oxida-
tion in acidotic rats was even more striking when rates were
calculated using the plasma a-ketoisocaproic acid specific ra-
dioactivity (Table 3). This is to be expected since the ratio of
plasma a-KIC to leucine specific radioactivities was lower in
the acidotic animals. In addition to the higher flux and oxidation
rates, a greater fraction of the amino acid flux was oxidized by
the acidotic rats (25 1%, acid vs. 19 1% control, P < 0.001).
Calculated rates of protein synthesis were statistically higher in
acidotic rats when they were calculated using the plasma
a-ketoisocaproate specific radioactivity. Thus, there is a higher
rate of protein turnover in acidotic rats, as well as excessive
amino acid oxidation, and hence a higher rate of net protein
degradation, at least in the postabsorptive period.
Discussion
The results of the present study extend our prior in vitro
observations to the examination of protein turnover in vivo
using stochastic modeling. The assumptions for modeling amino
acid turnover have been well reviewed [14], and can be mini-
mized by studying animals in a steady state, We used an open
four-pool model in which intracellular leucine and a-ketoiso-
caproate are in equilibrium by virtue of branched-chain amino
acid transaminases, and the respective intracellular and plasma
pools for ketoacid and amino acids bear a steady relationship.
The kinetic data were analyzed using both a primary pool
calculation (plasma leucine specific radioactivity) and a recip-
rocal pool method (plasma a-ketoisocaproate specific radioac-
tivity) [12, 14]. Animals were chronically catheterized so as to
minimize any effects on protein turnover of the catheter place-
ment, and small aliquots of plasma were removed at each
timepoint to minimize any changes in free amino acid pools.
Steady state was validated by demonstrating constancy of
plasma leucine and a-ketoisocaproate specific radioactivities
(Fig. 2), expired CO2 specific radioactivity (Fig. 1), and "CO2
production. In addition, plasma leucine concentrations did not
change appreciably during the course of the experiment, and
this is consistent with infusion of tracer leucine alone plus the
small volume of plasma removed for leucine specific radioac-
tivity determinations. We chose to study the animals 30 minutes
after achieving steady state in order to minimize any recycling
of the tracer that will occur if experimental observations are
delayed too long after beginning the infusion of tracer. It is
unlikely that recycling of tracer affected the results of the
present experiment, since this becomes a significant problem
only when tracer is infused over much longer periods of time
[24]. Moreover, any recycling would not explain differences
between the two groups, since it would become quantitatively
more significant in the group with the faster rate of protein
turnover. Hence, any recycling of label would have a tendency
to minimize differences present between the two groups.
Under steady state conditions, there was a greater flux of
amino acid turnover in acidotic animals, whether the flux is
expressed in terms of plasma leucine specific radioactivity or
whether plasma a-ketoisocaproate specific radioactivity is used
(Table 3); the latter may provide a truer reflection of intracel-
lular leucine specific radioactivity [121. In the postabsorptive
period, amino acid flux represents amino acids released from
stores undergoing proteolysis since there is negligible amino
acid absorption from the gut under these conditions. The higher
amino acid flux present in the acidotic rats establishes that the
catabolic effect of acidosis on skeletal muscle extends to the
whole animal and is associated with accelerated breakdown of
body proteins. This observation underscores the importance of
skeletal muscle in determining rates of protein turnover in vivo.
Alternatively, other tissues may demonstrate a pH-sensitive
rate of proteolysis similar to skeletal muscle. Stochastic mod-
eling of amino acid turnover in vivo does not allow one to
separately assess the relative contributions of the various
tissues. Accelerated intracellular proteolysis could also cause a
greater dilution of the intracellular leucine pool relative to the
plasma leucine pool. This would explain the lower plasma
a-KIC to leucine specific radioactivity ratio present in the
acidotic animals. Whereas we have previously found that
acidosis did not accelerate muscle protein synthesis in vitro [1],
the present results demonstrate that acidosis also increases
amino acid incorporation into body protein in vivo, Whether
these differences reflect differences in skeletal muscle protein
synthesis in vivo versus in vitro or whether other tissues are
responsible for these differences is not known.
In addition to acidosis accelerating the rate of protein turn-
over, we found that acidosis is associated with striking alter-
ations in leucine oxidation. Under steady state conditions,
acidosis stimulated leucine oxidation, irrespective of whether
plasma leucine or a-KIC specific radioactivities (Table 3) were
used to estimate the precursor specific radioactivity. For each
group we documented the stability of expired CO2 specific
radioactivity and separately determined the fractional recovery
for '4C02. Hence, these differences cannot be explained by
deviations from steady state nor from differences in the frac-
tional recovery of '4C02. The greater leucine oxidation in
acidotic animals is consistent with our prior observations indi-
cating that metabolic acidosis increases BCKAD activity as
determined on skeletal muscles freeze-clamped in situ [3]. We
have extended these observations in the present study by
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showing that liver BCKAD activity is likewise increased in vivo
when liver homogenates are prepared from acidotic animals
(Table 2). These findings are especially noteworthy since most
conditions associated with accelerated BCAA oxidation are
associated with increases in plasma leucine concentrations
[25—27] whereas acidosis causes a reduction in BCAA levels.
The differences in leucine oxidation cannot be explained by
different dietary protein intakes since rats in each group re-
ceived identical diets by gavage. Since both liver and skeletal
muscle BCKAD activity are increased by acidosis, it is not
possible to independently assess the relative importance of
extrasplanchnic vs splanchnic tissues in mediating the effects of
acidosis. Findings from earlier ablative experiments had been
interpreted to indicate an apparent equal contribution of 40% by
both liver and skeletal muscle on BCAA oxidation with most of
the balance due to kidney metabolism [28]. Interestingly, kid-
ney BCKAD activity was lowered by acidosis, thus demon-
strating the tissue specificity of the changes seen. Others have
shown the different effects of dietary protein intake on muscle,
liver, and kidney BCKAD activity [291. We extend these
findings to show that these tissues regulate BCKAD differently
in response to the pathophysiologic stimulus of metabolic
acidosis.
When leucine is labeled with "C in the first carbon, there are
limited pathways for the label. Under steady state conditions
"C can be incorporated into tissue protein, or the '4C can be
eliminated by the first committed step of leucine metabolism by
BCKAD where it enters the bicarbonate pool and is eliminated
as '4C02 [30]. Since the flux of L-[l-14C] leucine in the
postabsorptive period represents proteolysis, the oxidative flux
must represent the leucine which has undergone metabolism
and is no longer available for incorporation into protein, and
hence represents the net rate of protein degradation. We
conclude that chronic metabolic acidosis not only accelerates
the rate of body protein turnover, but also leads to an increase
in the net catabolism of protein, presumably by stimulating
amino acid degradative pathways and thereby preventing the
reincorporation of amino acids into protein. This would explain
the stunted growth and higher rates of urinary nitrogen excre-
tion in acidotic animals [1].
We have previously found that branched-chain amino acid
degradation is accelerated in vitro in muscles of rats with
acidosis accompanying chronic renal failure [31]. Moreover,
these findings were accompanied by lower plasma branched-
chain amino acid concentrations among the uremic rats. Both
the accelerated muscle BCAA flux as well as the lower plasma
BCAA concentrations were corrected by supplementing the
uremic animals with sufficient NaHCO3 to repair the acidosis.
Thus it appears likely that metabolic acidosis accompanying
chronic renal failure in rats likewise leads to accelerated amino
acid oxidation in vivo as well as in vitro.
The pathways controlling protein turnover remain obscure;
different pathways may be of greater quantitative importance in
various tissues [32]. For instance, lysosomes appear to mediate
a considerable portion of intracellular proteolysis in liver [33],
whereas the use of conventional lysosomal inhibitors has re-
vealed little effect of lysosomal inhibition on protein turnover in
skeletal muscle [34]. This study cannot define the operative
pathways mediating these effects of acidosis to accelerate
protein turnover. Nevertheless, we have found that the accel-
erated proteolysis is accompanied by an increase in the activity
of the BCAA-degrading enzyme, BCKAD. The relationships
between protein turnover, and essential amino acid degrading
enzyme activity are unclear but are likely to be nutritionally
significant, especially when dietary protein intake becomes
limiting.
Certain clinical findings suggest that these observations may
be relevant to humans. It is well known that infants with renal
tubular acidosis demonstrate stunted growth, and that the
growth rate is improved by eliminating the acidemia with
supplemental sodium bicarbonate [35]. Moreover, nitrogen
excretion in response to prolonged starvation is lessened by
repairing the starvation ketoacidosis with supplemental
NaHCO3 [36]. Nitrogen balance among patients with chronic
renal failure is improved by aggressive treatment of the accom-
panying acidosis with supplemental bicarbonate [37]. There is
also suggestive evidence that the degree of acidosis accompa-
nying chronic renal failure may affect the metabolism of
branched-chain amino acids. Bergstrom, Alvestrand and Furst
have found a striking direct correlation between the predialysis
plasma bicarbonate concentration and the valine concentrations
measured from skeletal muscle biopsies in these patients [38].
Whether humans will show changes in amino acid turnover and
branched-chain oxidative decarboxylation in response to
chronic metabolic acidosis similar to the present study remains
to be studied.
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